• Article metrics
  • Last updated: Fri, 10 Oct 2025 0:04:55 Z

Anlotinib vs placebo as third- or further-line treatment for patients with small cell lung cancer: a randomised, double-blind, placebo-controlled Phase 2 study

Access & Citations

  • 1221
    Article Accesses
  • 139
    Citations

Citation counts are provided by Dimensions and depend on their data availability. Counts will update daily, once available.

Online attention

Altmetric score 1
  • 3 tweeters
  • 40 Mendeley

This article is in the 31st percentile (ranked 260,507th) of the 444,800 tracked articles of a similar age in all journals and the 20th percentile (ranked 65th) of the 93 tracked articles of a similar age in British Journal of Cancer

View more on Altmetric

Altmetric calculates a score based on the online attention an article receives. Each coloured thread in the circle represents a different type of online attention. The number in the centre is the Altmetric score. Social media and mainstream news media are the main sources that calculate the score. Reference managers such as Mendeley are also tracked but do not contribute to the score. Older articles often score higher because they have had more time to get noticed. To account for this, Altmetric has included the context data for other articles of a similar age.